Brussels: On Jan 27, the European Union’s drug regulator gave the green light to Pfizer Inc’s (PFE.N) antiviral COVID-19 pill for treating high-risk patients. EU health commissioner Stella Kyriakides said the bloc was now making good progress on lining up treatments, which she described as ‘a second line of defense after vaccines’. “Paxlovid is the first oral antiviral for home use in our portfolio, and has the potential to make a real difference for persons at high risk of progression to severe COVID,” she said.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Israeli fighter jets strike Hezbollah positions in Lebanon

The Israeli military has said that its fighter jets struck several Hezbollah…

Fresh magnitude 5.0 earthquake strikes Türkiye’s Hatay

A fresh magnitude 5.0 earthquake has hit Türkiye’s southern Hatay province, according…

PM Sharif calls for honouring financial pledges against climate change

Prime Minister Shehbaz Sharif has called on the global community to honour…

Syria diverts flights to Latakia after air strikes on airports

Flights to and from Syria would operate from the Mediterranean province of…